Agilent Acquires Luxcel Biosciences

Agilent stock is up heading into the announcement that the company acquired Luxcel Biosciences. I think the stock has run up too far to be a good entry right now.

Agilent Technologies has acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based from vitro cell assay kits. This acquisition expands Agilent's cell evaluation portfolio with the inclusion of easy-to-use assay kits which are compatible with industry standard plate-readers.

Cambrex Corporation Oversold and Rising Large Players Volume

Cambrex Corporation stock was oversold and then it reported an impressive earnings and revenue surprise.

Cambrex Corporation reported EPS of $0.55 versus the estimate of $0.48. Revenue also beat coming in at $112.60 million versus the $108.44 million estimate. Revenue was up 13.4% on a year-over-year basis.

Sofi AI Market Sentiment Gauge

Sofi AI Market Sentiment Gauge

Market is neither overbought or oversold.